Seismic Therapeutic announced the appointment of Brendan St. Amant as general counsel.

Prior to joining Seismic, St. Amant was general counsel and corporate secretary for Synlogic, a publicly traded biotech company with a phase 3 clinical drug program.

Previously, he was vice president, legal, and member of the leadership team at Ohana Biosciences and was senior counsel at Vertex Pharmaceuticals.